Observational studyMedicina (Kaunas, Lithuania)2026
Preliminary Real-World Experience with Semaglutide in Obese Patients with Type 2 Diabetes on Chronic Hemodialysis: A Multicenter Pilot Study.
Alejandra Yugueros, Luis D'Marco, Alejandro Valero, Elena Vivó, Amparo Martínez-Mas, Manuel Calvé, Juan Carlos Alonso, Belén Vizcaíno, Mercedes González-Moya, Ana Checa-Ros and 2 more
Abstract readMulticenter StudyObservational Study
In one paragraphObservational study in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Luis D'MarcoGrupo de Investigación en Enfermedades Cardiorrenales y Metabólicas, Departamento de Medicina y Cirugía, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, CEU Universities, 46113 Valencia, Spain.ORCID 0000-0003-0148-891X Alejandro ValeroServicio de Nefrología, Hospital Doctor Peset, 46017 Valencia, Spain.
Elena VivóServicio de Nefrología, Hospital de la Ribera, 46600 Alzira, Spain.
Amparo Martínez-MasServicio de Nefrología Hospital Lluis Alcanyis de Xativa, 46800 Valencia, Spain.
Manuel CalvéServicio de Nefrología Hospital Lluis Alcanyis de Xativa, 46800 Valencia, Spain.
Juan Carlos AlonsoServicio de Nefrología Hospital Lluis Alcanyis de Xativa, 46800 Valencia, Spain.
Belén VizcaínoServicio de Nefrología, Hospital Doctor Peset, 46017 Valencia, Spain.
Mercedes González-MoyaServicio de Nefrología, Hospital Doctor Peset, 46017 Valencia, Spain.
Ana Checa-RosGrupo de Investigación en Enfermedades Cardiorrenales y Metabólicas, Departamento de Medicina y Cirugía, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, CEU Universities, 46113 Valencia, Spain.ORCID 0000-0001-8958-6711 Asunción SanchoServicio de Nefrología, Hospital Doctor Peset, 46017 Valencia, Spain.
Pablo MolinaServicio de Nefrología, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.ORCID 0000-0002-8311-6214 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 2Glucagon-Like PeptidesObesityAgedBody Mass IndexFemaleHumansHypoglycemic AgentsMaleMiddle AgedPilot ProjectsProspective StudiesRenal DialysisSemaglutideGlucagon-Like PeptidesHypoglycemic AgentsSemaglutidechronic kidney diseasediabetesGLP1-RAhemodialysisobesitysemaglutide
Identifiers
PMID41752784
PMCPMC12942463
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390